ERBB2 and neoplasm: Additionally, we found that tumor grade was the factor accounting for the greatest level of racial and ethnic disparities in pCR rates among patients with HR+/ERBB2− subtype, and the ERBB2/CEP17 ratio was an important factor accounting for racial disparities in pCR rates among patients with HR−/ERBB2+ subtype.